These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37843897)

  • 1.
    Lunn S
    Cannabis Cannabinoid Res; 2024 Feb; 9(1):432-433. PubMed ID: 37843897
    [No Abstract]   [Full Text] [Related]  

  • 2. Medical use of cannabis products: Lessons to be learned from Israel and Canada.
    Ablin J; Ste-Marie PA; Schäfer M; Häuser W; Fitzcharles MA
    Schmerz; 2016 Feb; 30(1):3-13. PubMed ID: 26767992
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Minhas M; Lunn SE
    Cannabis Cannabinoid Res; 2022 Oct; 7(5):719-721. PubMed ID: 35532992
    [No Abstract]   [Full Text] [Related]  

  • 4. Why Insurance Companies Should Pay for Medical Cannabis.
    Casarett D; Abrams DI
    Am J Bioeth; 2019 Apr; 19(4):8-10. PubMed ID: 30994419
    [No Abstract]   [Full Text] [Related]  

  • 5. Implications of the 2018 Canadian Cannabis Act: Should regulation differ for medicinal and non-medicinal cannabis use?⋆.
    Cox C
    Health Policy; 2021 Jan; 125(1):12-16. PubMed ID: 33208249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical Marijuana programs: implications for cannabis control policy--observations from Canada.
    Fischer B; Kuganesan S; Room R
    Int J Drug Policy; 2015 Jan; 26(1):15-9. PubMed ID: 25287942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cannabis as a therapeutic agent: Focal topic].
    Radbruch L; Schäfer M
    Schmerz; 2016 Feb; 30(1):1-2. PubMed ID: 26809973
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter to the editor: reflections on the future of medical cannabis research for depression.
    Erridge S; Mangoo S; Sodergren MH
    Expert Rev Neurother; 2023 May; 23(5):481-482. PubMed ID: 37078172
    [No Abstract]   [Full Text] [Related]  

  • 9. Barriers in accessing medical cannabis for children with drug-resistant epilepsy in Canada: A qualitative study.
    Elliott J; DeJean D; Potter BK; Coyle D; Clifford T; McCoy B; Wells GA
    Epilepsy Behav; 2020 Oct; 111():107120. PubMed ID: 32570201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing medical cannabis in Canada: Are we being too cautious?
    Lake S; Kerr T; Montaner J
    Can J Public Health; 2015 Apr; 106(5):e328-30. PubMed ID: 26451996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Position Statement on the Use of Medical Cannabis for the Treatment of Epilepsy in Canada.
    Appendino JP; Boelman C; Brna PM; Burneo JG; Claassen CS; Connolly MB; De Guzman MVT; Federico P; Floyd D; Huntsman RJ; Javidan M; Jette N; Jurasek LL; Keezer MR; Lau JC; McCoy B; McLachlan RS; Ng MC; Nguyen DK; Reid AY; Rho JM; Snead OC; Téllez-Zenteno JF; Wang L; Zak MM
    Can J Neurol Sci; 2019 Nov; 46(6):645-652. PubMed ID: 31466531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis use for symptom relief in multiple sclerosis: A cross-sectional survey of webinar attendees in the US and Canada.
    Hildebrand A; Minnier J; Cameron MH
    Mult Scler Relat Disord; 2020 Feb; 38():101516. PubMed ID: 31855842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermatology-Related Uses of Medical Cannabis Promoted by Dispensaries in Canada, Europe, and the United States.
    Lim M; Kirchhof MG
    J Cutan Med Surg; 2019; 23(2):178-184. PubMed ID: 30380925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association.
    Page RL; Allen LA; Kloner RA; Carriker CR; Martel C; Morris AA; Piano MR; Rana JS; Saucedo JF;
    Circulation; 2020 Sep; 142(10):e131-e152. PubMed ID: 32752884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the regulation of medical cannabis in Canada to better serve pediatric patients.
    Huntsman RJ; Kelly LE; Alcorn J; Appendino JP; Bélanger RE; Crooks B; Finkelstein Y; Gilpin A; Lewis E; Litalien C; Jacobs J; Moore-Hepburn C; Oberlander T; Rassekh SR; Repetski AE; Rieder MJ; Shackelford A; Siden H; Szafron M; 't Jong GW; Vaillancourt R;
    CMAJ; 2021 Oct; 193(41):E1596-E1599. PubMed ID: 34663604
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical Use of Marijuana: The Thin Line Between Good and Evil?
    Salazar J; Rojas M; Espinoza C
    Arch Med Res; 2018 Aug; 49(6):421-422. PubMed ID: 30595363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marijuana: a time-honored but untested treatment for epilepsy.
    McLachlan RS
    Can J Neurol Sci; 2015 Mar; 42(2):88-91. PubMed ID: 25715711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical cannabis: strengthening evidence in the face of hype and public pressure.
    Fitzcharles MA; Shir Y; Häuser W
    CMAJ; 2019 Aug; 191(33):E907-E908. PubMed ID: 31427354
    [No Abstract]   [Full Text] [Related]  

  • 19. Calling for Openness to the Study of Cannabis Use in Chronic Pelvic Pain.
    Manz J; Hyakutake M; Kelly E
    J Obstet Gynaecol Can; 2021 May; 43(5):611-613. PubMed ID: 33132057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cohort study of medical cannabis authorisation and healthcare utilisation in 2014-2017 in Ontario, Canada.
    Eurich D; Lee C; Zongo A; Minhas-Sandhu JK; Hanlon JG; Hyshka E; Dyck J
    J Epidemiol Community Health; 2020 Mar; 74(3):299-304. PubMed ID: 31831619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.